Get your Emails warmed up and ready to send
Build sender reputation and reach more inboxes with automated email warmup.
Warm up your emails
Starting at $49/month
Adam Czernik
Director, Program Delivery Leader, Immunology @Johnson & Johnson Innovative Medicine
Signup · Get unlimited contacts
WORK HISTORY
Director, Program Delivery Leader, Immunology @Johnson & Johnson Innovative Medicine
Warsaw, PL
Single point of accountability for providing strategic operational input to the clinical development plan, building the strategic operational plan and budget for Global Development deliverables and milestones. Provides global leadership to the execution to plan and/or define risk mitigation strategies and ensures implementation at program level. Oversees CRO work in outsourced studies.3. Creates and gains endorsement of the global strategic operational plan (compound/program level), inclusive of the sourcing strategy, supplier selection strategy, an aligned country selection plan and ensures an integrated data plan for external data streams is available and endorsed.4. Ensures the predictable delivery of clinical operations activities across the program within the agreed upon budget and timelines. Oversees clinical trial budget forecasting and management inclusive of costs and FTE estimates. Is accountable for budget and change control at the program level.
EDUCATION
Akademia Medyczna w Warszawie
Medical Doctor
Politechnika Warszawska in cooperation with London Business School/HEC
MBA
SKILLS
ABOUT ADAM CZERNIK
Influential in strategic choices and global studies in cutting-edge therapeutic areas such as CAR-T. Achieved exceptional recruitment rates and surpassed DEI targets in a key Immunology program. Successfully led clinical operations redesign and collaboration efforts in Poland and Germany. Experienced leader of large, diverse scientific teams, nurturing talent up to Associate Director/Director level. Led strategic initiatives for the Clinical Research Working Group in Poland\'s Industry Association. Designed and executed RBM strategy, implementing new oversight procedures for Quality Tolerance Limits. Currently developing: Oncology Compound Development Team Lead bench program. CDTL coordinates all aspects of clinical development, collaborating with cross-functional experts spanning basic science, FIH, ED/LD, global regulatory, and commercial/reimbursement.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.